| Phase 16 trials |
|
Phase 1
|
NCT03807063 |
Jan → Dec 2020 |
B-cell chronic lymphocytic leukemia, CD4+/CD56+ hematodermic neoplasm, acute biphenotypic leukemia, bilineal acute myeloid leukemia +4 |
Fred Hutchinson Cancer Center |
Withdrawn
|
No outcome recorded
|
|
Phase 1
|
NCT03459170 |
Feb 2018 → Sep 2022 overdue |
hematopoietic and lymphoid cell neoplasm |
Bellicum Pharmaceuticals |
Active not recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT02487459 |
Jul 2016 → Jun 2017 |
hematopoietic and lymphoid cell neoplasm |
Bellicum Pharmaceuticals |
Withdrawn
|
No outcome recorded
|
|
Phase 1
|
NCT02477878 |
Jul 2016 → Jan 2020 overdue |
leukemia, myelodysplastic syndrome, plasma cell myeloma |
Bellicum Pharmaceuticals |
Active not recruiting
|
No outcome recorded
|
|
Phase 1
|
NCT02786485 |
May 2016 → Dec 2018 |
leukemia, myelodysplastic syndrome, plasma cell myeloma |
Bellicum Pharmaceuticals |
Withdrawn
|
No outcome recorded
|
|
Phase 1
|
NCT02231710 |
Feb → Sep 2015 |
bone marrow failure syndrome, hemoglobinopathy, hemophagocytic syndrome, immunodeficiency disease +1 |
Bellicum Pharmaceuticals |
Terminated
|
No outcome recorded
|
| Phase 1/24 trials |
|
Phase 1/2
|
NCT03733249 |
Jan 2017 → Jun 2020 |
Diamond-Blackfan anemia, Fanconi anemia, acute lymphoblastic leukemia, childhood acute myeloid leukemia +5 |
Bellicum Pharmaceuticals |
Terminated
|
No outcome recorded
|
|
Phase 1/2
|
NCT03301168 |
Apr 2014 → May 2021 overdue |
acute lymphoblastic leukemia, aplastic anemia, childhood acute myeloid leukemia, hemoglobinopathy +3 |
Bellicum Pharmaceuticals |
Active not recruiting
|
No outcome recorded
|
|
Phase 1/2
|
NCT02065869 |
Apr 2014 → Jun 2020 |
Diamond-Blackfan anemia, Fanconi anemia, acute lymphoblastic leukemia, childhood acute myeloid leukemia +5 |
Bellicum Pharmaceuticals |
Terminated
|
No outcome recorded
|
|
Phase 1/2
|
NCT01744223 |
Mar 2013 → Oct 2019 overdue |
acute lymphoblastic leukemia, acute myeloid leukemia, myelodysplastic syndrome |
Bellicum Pharmaceuticals |
Active not recruiting
|
No outcome recorded
|
| Phase 2/31 trial |
|
Phase 2/3
|
NCT03699475 |
Dec 2018 → Jul 2019 |
acute myeloid leukemia, myelodysplastic syndrome |
Bellicum Pharmaceuticals |
Terminated
|
No outcome recorded
|
| Phase not stated1 trial |
| — |
NCT03639844 |
— |
Hurler syndrome, metachromatic leukodystrophy |
Bellicum Pharmaceuticals |
No longer available
|
No outcome recorded
|